Your browser doesn't support javascript.
loading
Lymphocyte activation gene 3: a novel therapeutic target in chronic lymphocytic leukemia.
Shapiro, Mika; Herishanu, Yair; Katz, Ben-Zion; Dezorella, Nili; Sun, Clare; Kay, Sigi; Polliack, Aaron; Avivi, Irit; Wiestner, Adrian; Perry, Chava.
Affiliation
  • Shapiro M; Department of Hematology, Tel Aviv Sourasky Medical Center, Israel.
  • Herishanu Y; Department of Hematology, Tel Aviv Sourasky Medical Center, Israel yairh@tlvmc.gov.il.
  • Katz BZ; Sackler Faculty of Medicine, Tel Aviv University, Israel.
  • Dezorella N; Department of Hematology, Tel Aviv Sourasky Medical Center, Israel.
  • Sun C; Sackler Faculty of Medicine, Tel Aviv University, Israel.
  • Kay S; Department of Hematology, Tel Aviv Sourasky Medical Center, Israel.
  • Polliack A; Sackler Faculty of Medicine, Tel Aviv University, Israel.
  • Avivi I; Hematology Branch, National Heart, Lung, and Blood Institute, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  • Wiestner A; Department of Hematology, Tel Aviv Sourasky Medical Center, Israel.
  • Perry C; Hadassah University Hospital, Jerusalem, Israel.
Haematologica ; 102(5): 874-882, 2017 05.
Article in En | MEDLINE | ID: mdl-28154084
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Lymphocyte Activation / Leukemia, Lymphocytic, Chronic, B-Cell / Histocompatibility Antigens Class II / Antigens, CD Limits: Humans Language: En Journal: Haematologica Year: 2017 Document type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Lymphocyte Activation / Leukemia, Lymphocytic, Chronic, B-Cell / Histocompatibility Antigens Class II / Antigens, CD Limits: Humans Language: En Journal: Haematologica Year: 2017 Document type: Article